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The etiology of mammalian senescence is suggested to involve the progressive impairment of mitochondrial function; 
however, direct observations of age-induced alterations in actual respiratory chain function are lacking. Accordingly, 
we assessed mitochondrial function via high-resolution respirometry and mitochondrial protein expression in soleus, 
quadricep, and lateral gastrocnemius skeletal muscles, which represent type 1 slow-twitch oxidative muscle (soleus) and 
type 2 fast-twitch glycolytic muscle (quadricep and gastrocnemius), respectively, in young (10–12 weeks) and mature 
(74–76 weeks) mice. Electron transport through mitochondrial complexes I and III increases with age in quadricep and 
gastrocnemius, which is not observed in soleus. Mitochondrial coupling efficiency during respiration through complex 
I also deteriorates with age in gastrocnemius and shows a tendency (p = .085) to worsen in quadricep. These data dem-
onstrate actual alterations in electron transport function that occurs with age and are dependent on skeletal muscle type.
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AN inherent flaw of the bioenergetic reliance on  aerobic metabolism to sustain life is the corollary 
oxidant production (1), and consequently mitochondria 
serve as the primary source of in vivo oxidant produc-
tion (2–5). Mitochondria-derived reactive oxygen species 
are largely accounted for by superoxide (O2−) production 
into the mitochondrial matrix at mitochondrial complex 
I  (CI) (6–8) and into both the matrix and mitochondrial 
intermembrane space at mitochondrial complex III (CIII) 
(9–14). The progression of reactive oxygen species pro-
duction beyond hormetic concentrations precipitates del-
eterious and indiscriminate oxidation of nucleic acids, 
proteins, and lipids (5,15,16). These pernicious effects 
then correspondingly impair mitochondrial function, 
which result in greater oxidant production, and so on 
leading to a “vicious cycle” and eminent cellular demise 
(4,15,17). The mitochondrial theory of aging asserts that 
the biological aging process is facilitated by this progres-
sive accrual of mitochondrial DNA (mtDNA) damage 
and reciprocal decline of mitochondrial function (18). 
Although evidence of increasing mtDNA alteration with 
age is supported by the literature, data suggestive of an 
impairment of mitochondrial function with aging are 
inconsistent.
Senescence corresponds with mounting indications of 
nuclear and mtDNA damage in both humans and animals 
(19–22). Moreover, mtDNA facilitated mutations lead to 
premature aging in mice (23) and humans (24). Transgenic 
studies show that reducing whole-body or tissue-specific 
mitochondrial superoxide dismutase, the enzyme that catal-
yses the dismutation of mitochondria-generated O2− to H2O2 
(25), increases evidence of oxidative damage and premature 
aging (26–28). Alternatively, overexpression of endogenous 
mitochondrial catalase lessens oxidant damage, reduces an 
overall burden of disease (29), and increases life span (30). 
Indications of impaired mitochondrial function extend-
ing beyond measures of oxidant production or damage are 
lacking. Whether there are age-induced alterations in actual 
electron transport function remain unanswered (4).
Reports of functional impairments to mitochondria with 
aging are seemingly paradoxical. Mitochondrial enzymatic 
expression, protein synthesis, volume density, and oxidative 
capacity have been reported to decrease with age in humans 
and animals quadricep (QUAD) skeletal muscle (19,31–37) 
as well as in a collection of lower limb skeletal muscle 
representative of mixed glycolytic and oxidative fibers 
(38–40). The age-induced loss of mitochondrial protein 
expression and oxidative capacity, however, fails to decrease 
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in skeletal muscle primarily composed of type 2 fast-twitch 
glycolytic fibers (41–43). Modifications of mitochondrial 
content also differ with aging between m. vastus lateralis 
and m. gastrocnemius in humans (44). These differences 
have led to speculation that mitochondrial impairment with 
aging may differ across different skeletal muscle types 
(19,45). In vivo metabolic imaging techniques have provided 
preliminary evidence to support this assumption with skeletal 
muscle primarily composed of fast-twitch fibers exhibiting 
the greatest age-induced impairments (46,47).
Accordingly, the aim of this study is to examine mito-
chondrial protein expression along with analysis of respira-
tory capacity and control via high-resolution respirometry. 
Respirometric analyses using isolated mitochondrial prep-
arations have been reported to exaggerate age-induced 
changes in mitochondrial function (48). Mitochondrial 
isolation techniques disturb native mitochondrial reticu-
lar networks in skeletal muscle (49) producing atypi-
cal and individual organelles through unregulated means 
(50–52). This alters innate mitochondrial characteristics 
(48,53–60) such as the loss of mitochondrial membrane 
integrity (61,62) and the ability to oxidize fatty acids (56). 
For respirometric analysis, we use saponin-permeabilized 
skeletal muscle preparations. This preparation allows for 
direct access to skeletal muscle mitochondria while main-
taining both the cytocellular ultrastructure (51,63–68) and 
subcellular interactions with mitochondria (51,53,64,67–
69). Cellular bioenergetics and metabolic channeling are 
predicated upon these factors (63,64,67,70). We have pre-
viously demonstrated that respirometric analysis using this 
in situ preparation in conjunction with biochemical assess-
ment of mitochondria is more appropriate when attempt-
ing to differentiate between isolated changes in enzymatic 
expression versus an alteration in the functional capacity 
of a subcellular system (71–74). Accordingly, this spe-
cific mitochondrial preparation serves as the best model 
to examine respiratory capacity and control with aging. 
Respirometric analyses were carried out on soleus (SOL), 
QUAD, and lateral gastrocnemius (GAST) skeletal mus-
cles, which represent type 1 slow-twitch oxidative muscle 
(SOL) and type 2 fast-twitch glycolytic muscle (QUAD and 
GAST), respectively, in young (10–12 weeks) and mature 
(74–76 weeks) mice. Taking into account the inconsistent 
reports of mitochondrial impairment with age across dif-
ferent skeletal muscles, we hypothesize that alterations in 
mitochondrial function with age vary across skeletal mus-
cle types, explaining the seemingly inconsistent past find-
ings on this topic.
Experimental Procedures
Ethical Approval
The experimental protocols using laboratory animals 
were approved by the Kantonales Veterinäramt Zürich 
(217/2010) and were performed in accordance with the 
Swiss animal protection laws and institutional guidelines.
Experimental Animals
A total of 24 male C57Bl/6 mice were used in the comple-
tion of this study, 12 young (10–12 week old) and 12 mature 
(74–76 week old) mice. All mice were housed in standard 
rodent cages (T3) with fixed temperature (21 ± 1°C), free 
access to food and water, and a 12-hour light–dark cycle. 
Animals were euthanized by means of carbon dioxide fol-
lowed by rapid excision of SOL, QUAD, and GAST. These 
muscles represent a type 1 slow-twitch oxidative muscle 
(SOL) and a type 2 fast-twitch glycolytic muscle (QUAD 
and GAST), respectively. The skeletal muscles from one leg 
were quickly excised and placed in ice-cold biopsy solu-
tion for immediate respirometric analyses. The correspond-
ing skeletal muscles from the opposite hind limb were then 
removed, frozen in liquid nitrogen, and stored at −80°C until 
processed for protein expression analysis (see Muscle Lysate 
Preparation, and Sodium Dodecyl Sulfate–Polyacrylamide 
Gel Electrophoresis and Western Blotting sections).
Muscle Lysate Preparation
The muscle samples were homogenized (Qiagen 
TissueLyser II, Retsch, Haan, Germany) in a fresh batch of 
buffer containing the following (in millimolar): 10% glycerol, 
20 sodium-pyrophosphate, 150 NaCl, 50 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES) (pH 7.5), 1% 
NP-40, 20 β-glycerophosphate, 2 Na3VO4, 10 NaF, 2 phe-
nylmethanesulfonyl fluoride, 1 ethylenediaminetetraacetic 
acid (pH 8.0), 1 ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA) (pH 8.0), 10 µg/mL apro-
tinin, 10  µg/mL leupeptin, and 3 benzamidine. Afterward 
samples were rotated end over end for 1 hour at 4°C and cen-
trifuged at 16,500g for 30 minutes at 4°C, and the supernatant 
(lysate) was used for further analysis. Total protein concen-
tration in each sample was determined by a bovine serum 
albumin standard kit (Pierce, Rockford, IL), and all samples 
were diluted to the same protein concentration in ddH2O and 
a modified 6× Laemmli buffer (7 mL 0.5 M Tris base [pH 
6.8], 3 mL glycerol, 0.93 g dithiothreitol, 1 g sodium dodecyl 
sulfate, and 1.2 mg bromophenol blue).
Sodium Dodecyl Sulfate–Polyacrylamide Gel 
Electrophoresis and Western Blotting
Methods have been previously described in detail (75–
77). Equal amounts (10 µg) of total muscle lysate proteins, 
determined during optimization of the different antibodies, 
were loaded in each well. Samples were loaded together with 
protein markers (Precision Plus All Blue and Dual Color, 
Bio-Rad Laboratories, Hercules, CA) on precasted gels 
(Bio-Rad Laboratories). Proteins were separated by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis and 
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semidry transferred to a polyvinylidene fluoride membrane 
(Millipore). The membranes were blocked in either 
2% skimmed milk or 3% bovine serum albumin in Tris-
buffered saline, including 0.1% Tween 20 before an 
overnight incubation in primary antibody at 4°C. Thereafter, 
membranes were washed in Tris-buffered saline, including 
0.1% Tween 20 and incubated for 1 hour at room temperature 
in horseradish peroxidase-conjugated secondary antibody. 
Membranes were then washed 3  × 15 minutes in Tris-
buffered saline, including 0.1% Tween 20 before the bands 
were visualized with ECL (Millipore) and recorded with a 
digital camera (ChemiDoc MP Imaging System, Bio-Rad). 
Quantification of the Western blot band intensity was done 
using the Image Lab software programme (Bio-Rad) and 
determined as the total band intensity minus the background 
intensity. Primary antibodies were optimized by use of 
mouse muscle lysates to secure that the protein amount 
loaded would result in band signal intensities localized on 
the steep and linearly part of a standard curve. To determine 
changes in total protein expression, the following antibodies 
were used with the localization of the quantified signal 
noted: 3-hydroxyacyl coenzyme a dehydrogenase (HAD): 
83 kDa, polyclonal ab54477 (Abcam, UK); Mitochondrial 
Complex IV subunit 4, COXIV, (CIV): 16 kDa, monoclonal 
sc-58348 (Santa Cruz Biotechnology, Santa Cruz, CA); 
and Mitochondrial Complex I  subunit NDUFB8 (CI): 
20 kDa (monoclonal ab110242), Mitochondrial Complex II, 
Succinate Dehydrogenase complex subunit B (CII): 30 kDa 
(monoclonal ab14714), Mitochondrial Complex III subunit 
Core 2 (CIII): 45 kDa (monoclonal ab14745), Mitochondrial 
Complex V ATP Synthase subunit alpha (CV): 55 kDa 
(monoclonal ab14748) all four included in the MitoProfile 
Total OXPHOS Human WB Antibody Cocktail (ab110411, 
Abcam). The secondary antibodies used were horseradish 
peroxidase-conjugated goat anti-mouse and goat anti-rabbit 
(P-0447 and P-0448, DAKO, Denmark). All samples from 
the same muscle type were loaded on the same gel with 
young and mature muscles mixed. Signal intensity from 
each muscle sample was normalized to the mean signal 
intensity of the human standard.
Skeletal Muscle Preparation
Each part was immediately placed in ice-cold biopsy 
preservation solution containing 2.77 mM CaK2EGTA 
buffer, 7.23 mM K2EGTA buffer, 0.1  µM free calcium, 
20 mM imidazole, 20 mM taurine, 50 mM 2-(N-morpholino)
ethanesulfonic acid hydrate (K-MES), 0.5 mM dithiothreitol, 
6.56 mM MgCl2•6H2O, 5.77 mM ATP, and 15 mM phospho-
creatine (pH 7.1). Muscle samples were then gently dissected 
with a pair of fine-tipped forceps achieving a high degree of 
fiber separation verified microscopically. Chemical permea-
bilization followed via incubation in 2 mL of biopsy pres-
ervation solution with saponin (50 μg/mL) for 30 minutes 
in 4°C. Last, samples were washed with a mitochondrial 
respiration medium (MiR05) containing 0.5 mM EGTA, 
3 mM MgCl2•6H2O, 60 mM K-lactobionate, 20 mM taurine, 
10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose, and 1 g/L 
bovine serum albumin (pH 7.1) for 10 minutes at 4°C.
Mitochondrial Respiration Measurements
Muscle bundles were blotted dry and measured for wet 
weight in a balance-controlled scale (XS205 DualRange 
Analytical Balance, Mettler-Toledo AG, Switzerland) main-
taining constant relative humidity, providing hydration 
consistency as well as stability of weight measurements. 
Respiration measurements were performed in mitochondrial 
respiration medium 06 (MiR06; MiR05 + catalase 280 IU/
mL). Measurements of oxygen consumption were performed 
at 37°C using the high-resolution Oxygraph-2k (Oroboros, 
Innsbruck, Austria) with all additions in each substrate, 
uncoupler, and inhibitor titration protocol added in series. 
Standardized instrumental calibrations were performed to 
correct for back diffusion of oxygen into the chamber from 
the various components, leak from the exterior, oxygen 
consumption by the chemical medium, and sensor oxygen 
consumption. Oxygen flux was resolved by software allow-
ing nonlinear changes in the negative time derivative of the 
oxygen concentration signal (Oxygraph-2k, Oroboros). All 
experiments were carried out in a hyperoxygenated environ-
ment to prevent any potential oxygen diffusion limitation.
Respiratory Titration Protocols
Each titration protocol was specific to the examination of 
individual aspects of respiratory control through a sequence 
of coupling and substrate states induced via separate titra-
tions, which were added in series as presented. The concen-
trations of substrates, uncouplers, and inhibitors used were 
based on prior experiments conducted for optimization of 
the titration protocols (71–73). A  description of all three 
protocols is given in Table 1.
Table 1. Respirometric Titration Protocols
1 M: 2 mM OC: 0.2 mM ADP: 5 mM G: 10 mM S: 10 mM Cyt C: 10 μM FCCP: 1.5–3 µM Rot: 0.5 μM AmA: 2.5 μM
2 M: 2 mM P: 5 mM ADP: 5 mM Cyt C: 10 μM FCCP: 1.5–3 µM Rot: 0.5 μM AmA: 2.5 μM — —
3 Rot: 0.5 μM S: 10 mM ADP: 5 mM Cyt C: 10 μM FCCP: 1.5–3 µM AmA: 2.5 μM — — —
Notes: The three different titration protocols utilized in this study. Each row presents the substrate, uncoupler, or inhibitor and concentration titrated into the 
respiration medium, with all additions occurring sequentially as presented from left to right. ADP = adenosine diphosphate; AmA = antimycin A; Cyt C = cytochrome 
c; FCCP = carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone; G = glutamate; M = malate; OC = octanoyl carnitine; Rot = rotenone; S = succinate.
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Titration protocol 1
 • Leak respiration in absence of adenylates (LN) was 
induced with the addition of malate (2 mM) and octanoyl 
carnitine (0.2 mM). The LN state represents the resting 
oxygen consumption of an unaltered and intact electron 
transport system (ETS) free of adenylates.
 • Maximal electron flow through electron-transferring 
flavoprotein (ETF) and fatty acid oxidative capacity, 
PETF, were both determined following the addition of 
ADP (5 mM). In the PETF state, the ETF-linked transfer of 
electrons requires the metabolism of acetyl-CoA, hence 
the addition of malate, in order to facilitate convergent 
electron flow into the Q-junction from both CI and 
ETF allowing β-oxidation to proceed. The contribution 
of electron flow through CI is far below capacity and 
so here the rate-limiting metabolic branch is electron 
transport through ETF such that malate + octanoyl 
carnitine + ADP-stimulated respiration is representative 
of, rather than specific to, electron capacity through ETF 
(71,78,79).
 • Submaximal state 3 respiratory capacity specific to CI, 
PCI, was induced following the additions of glutamate 
(10 mM).
 • Maximal state 3 respiration, oxidative phosphorylation 
capacity, P, was then induced with the addition of suc-
cinate (10 mM). P demonstrates a naturally intact ETS’s 
capacity to catalyze a sequential set of redox reactions 
that are partially coupled to the production of ATP via 
ATP Synthase. P maintains an electrochemical gradient 
across the inner mitochondrial membrane dictated by 
the degree of coupling to the phosphorylation system 
(63,65). This maximal state 3 state represents respira-
tion that is resultant to saturating concentrations of ADP 
and substrate supply for both CI and succinate dehydro-
genase, CII. Convergent electron input to CI and CII 
provides higher respiratory values compared with the 
isolated respiration of either CI (pyruvate and/or gluta-
mate + malate or glutamate + malate) or CII (succinate + 
rotenone) (63, 80). Consequently, P presents more phys-
iological relevance to the study of mitochondrial func-
tion (81) and is necessary to establish confirmation of a 
complete and intact ETS.
 • As an internal control for compromised integrity of 
the mitochondrial preparation, the mitochondrial outer 
membrane was assessed with the addition of cytochrome 
c (10 μM). If respiration significantly increased follow-
ing titration of cytochrome c, then the measurement 
was removed and not included in statistical analysis. 
There was no indication of mitochondrial damage in the 
measurements included in the study as demonstrated by 
the average 3.5%, 2.9%, 7.5%, 5.3%, 6.3%, and 2.3% 
change in young and mature QUAD, SOL, and GAST 
respiration, respectively. All were either below or within 
the accepted 5%–15% elevation in respiration following 
exogenous cytochrome c titration, successfully verifying 
the integrity of the outer mitochondrial membrane (64).
 • Phosphorylative restraint of electron transport was 
assessed by uncoupling ATP Synthase, CV from the ETS 
with the titration of the proton ionophore, and carbonyl 
cyanide p-(trifluoromethoxy) phenylhydrazone (0.5 μM 
per addition up to optimum concentrations ranging from 
1.5 to 3 µM) reaching ETS capacity. The inner mitochon-
drial membrane potential is completely collapsed with 
an open transmembrane proton circuit in the ETS res-
piratory state. The uninhibited flow of electrons through 
the respiratory system can, therefore, indirectly serve 
as an indication of maximal mitochondrial membrane 
potential.
 • Finally, rotenone (0.5  µM) and antimycin A  (2.5 μM) 
were added, in sequence, to terminate respiration by 
inhibiting CI and CIII, respectively. With CI inhibited, 
electron flow is specific to CII, providing submaximal 
state 3 respiration through CII (PCII).
•	 Inhibition of respiration with antimycin A  then allows 
for the determination and correction of residual oxygen 
consumption, indicative of nonmitochondrial oxygen 
consumption in the chamber.
Titration protocol 2.—This titration protocol was nec-
essary for determination of coupling control of electrons 
through CI.
 • LN–malate (2 mM) and pyruvate (5 mM).
 • PCI–ADP (5 mM).
 • Internal control for mitochondrial outer membrane 
integrity–cytochrome c (10  μM). There was no indi-
cation of mitochondrial damage in the measurements 
included in the study as demonstrated by the 0.3%, 
1.3%, 0.1%, −0.3%, 4.3%, and −0.1% change in mouse 
young and mature QUAD, SOL, and GAST respiration, 
respectively.
 • ETS–carbonyl cyanide p-(trifluoromethoxy) phenylhy-
drazone (0.5 μM per addition up to optimum concentra-
tions ranging from 1.5 to 3 µM).
 • CI inhibition–rotenone (0.5 µM).
•	 Residual oxygen consumption–antimycin A (2.5 μM).
Titration protocol 3.—This titration protocol was nec-
essary for determination of coupling control of electrons 
through CII.
 • CI inhibition–rotenone (0.5 µM).
 • LN–succinate (10 mM).
 • PCII–ADP (5 mM).
 • Internal control for mitochondrial outer membrane integ-
rity–cytochrome c (10 μM). There was no indication of 
mitochondrial damage in the measurements included 
in the study as demonstrated by the 7.3%, 2.6%, 9.8%, 
13.4%, 5.1%, and 7.3% change in mouse young and 
mature QUAD, SOL, and GAST respiration, respectively.
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 • ETS–carbonyl cyanide p-(trifluoromethoxy) phenylhy-
drazone (0.5 μM per addition up to optimum concentra-
tions ranging from 1.5 to 3 µM).
•	 Residual oxygen consumption–antimycin A (2.5 μM).
Respirometric values representing PCI and PCII did not differ 
across titration protocols. Consequently all PCI and PCII val-
ues achieved with the titration protocols for 2 and 3, respec-
tively, were grouped with complementing respiratory state 
from titration protocol 1.
Data Analysis
All mass-specific respirometric values were controlled 
to account for the differences in mitochondrial content, as 
indicated by CII protein expression, across age and fiber 
types. In doing so, all CII protein expression data were 
adjusted to a value of 1. The degree by which the protein 
expression had to be adjusted to equal 1 was then applied to 
all mass-specific respirometric values corresponding with 
the appropriate age and skeletal muscle type, respectively. 
Values of PCI controlling for CI protein expression, PETF 
controlling for HAD protein expression, and P controlling 
for CIII protein expression all were also adjusted using the 
same method.
For all statistical evaluations, a p value of less than .05 was 
considered significant. Differences in respiratory capacities 
and protein expression with age and across skeletal muscle 
groups were initially compared using a two-way analysis 
of variance. When an analysis of variance was significant, 
differences in respiratory capacities and protein expression 
with age and across skeletal muscle groups were evaluated 
using pairwise comparisons with a Bonferroni adjustment 
(SPSS Statistics 17.0, SPSS, Inc., Chicago, IL). Indices of 
mitochondrial efficiency did not express a Gaussian distri-
bution and therefore a Kruskal–Wallis analysis of variance 
and the Mann—Whitney U tests were used to reveal differ-
ences between younger and older muscle as well as com-
parisons across muscle groups within the respective age 
groups.
Results
Skeletal Muscle Protein Expression
As shown in Figure 1, protein expression for all mito-
chondrial enzymes was greatest in the slow-twitch SOL 
muscle. In young animals only the expression of CII and 
CIV differed between QUAD and GAST, both of which 
were lost with age. Only SOL expressed a change in mito-
chondrial protein content with age as CI, CII, and CV all 
increased (Figure 1A, B, and E, respectively). Though no 
significant changes in protein expression of CIII (Figure 1C) 
or CIV (Figure 1D) were apparent, both complexes showed 
a tendency to diminish with age in GAST (p  =  .060 and 
.063, respectively). Collectively, this analysis illustrates 
that the protein content for enzymes involved in mitochon-
drial oxidative phosphorylation is largely unaffected in pri-
marily fast-twitch glycolytic muscle (QUAD and GAST) 
but slightly increased in primarily slow-twitch oxidative 
muscle (SOL) with age.
Mitochondrial Respiration
Main effects of age on mass-specific respiration (pmol 
O2/min/mg ww) were observed for PETF (p = .011) and PCII 
(p = .008). This was reflected by the higher PETF and PCII in 
mature QUAD (p = .031 and .037, respectively; Figure 2E) 
and GAST (p  =  .011 and .016, respectively; Figure  2I) 
versus their younger counterparts. There was also a main 
effect of muscle type on mass-specific respiration as SOL 
has greater respiration across all states compared with both 
QUAD and GAST (p < .001; Figure 2A).
Mass-specific respiration does not take into account 
differences in mitochondrial content between samples 
(Figure  1). Accordingly, all respirometric analyses were 
adjusted for CII protein content, a biomarker shown to 
express the best concordance with mitochondrial content 
and total cristae area as measured by transmission elec-
tron microscopy as well as myocellular respiratory capac-
ity over protein concentrations for all other mitochondrial 
complexes (82). When controlling respiration to mitochon-
drial content, the main effect of age on respiration capacity 
(pmol O2/min/CII) appeared to be silenced by the divergent 
fluctuations in mitochondrial function across skeletal mus-
cle types in response to age. Respiratory states representing 
PCI, P, and ETS in QUAD and PCI, P, ETS, and PCII in SOL 
all lost respiratory capacity in response to age (Figure 2F 
and H). Conversely, GAST increased respiratory capacity 
at every respiratory state measured (Figure 2J) in response 
to age. The differences in respiratory capacity when con-
trolling for mitochondrial content across skeletal muscle 
in younger and older mice are shown in Figure 2B and D, 
respectively.
Respiratory Capacity and Coupling Control Specific to 
Mitochondrial Complexes I and III
Electron transport and control specifically through CI 
and CIII are of particular interest as reactive oxygen spe-
cies production at each respective complex accounts for the 
majority of mitochondria-specific oxidant production (9–
14). In order to isolate analysis to these specific complexes, 
all PCI values, including respirometric values from both 
titration protocols 1 and 2, and maximal state 3 respiromet-
ric values, P, were adjusted to account for the differences in 
CI and CIII protein expression, respectively, with age and 
across muscle groups (Figure 1A and C).
There were main effects of age (p = .001) on PC1 respira-
tion when controlling for CI expression (pmol O2/min/CI), 
which increased with age in both QUAD and GAST (p < 
.001) and decreased in SOL (p = .003; Figure 3A–C). The 
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coupling efficiency during PCI respiration deteriorated with 
age in GAST (p = .043) and showed a tendency to diminish 
in QUAD as well (p = .085; Table 2). Though no differences 
in respiratory capacity were observed across all young mus-
cle groups during PCI when controlling for CI, the coupling 
control was superior in young QUAD and GAST over SOL 
(p = .021 and .009, respectively). In the older muscle both 
QUAD and GAST presented with higher PCI than SOL 
(p < .001) and both, again, expressed a tighter coupling effi-
ciency than SOL (p = .004 and p < .001).
There were also main effects of age (p  =  .009) on 
maximal state 3 respiration and oxidative phosphorylation 
capacity, P, when controlling for CIII protein expression 
(pmol O2/min/CIII) (Figure 4A–C). Respiration capacity in 
both QUAD and GAST increased with age (p =  .009 and 
.001, respectively), whereas SOL did not change (p = .144). 
A B
C D
E F
Figure 1. Protein expression of mitochondrial complexes and proteins with age. Skeletal muscle protein expression determined in young (10–12 weeks) and 
mature (74–76 weeks) C57Bl/6 mice. Protein expression for (A) CI, mitochondrial complex I or NADH dehydrogenase; (B) CII, mitochondrial complex II or 
succinate dehydrogenase; (C) CIII, mitochondrial complex III or cytochrome bc1 complex; (D) CIV, mitochondrial complex IV or cytochrome c oxidase; (E) CV, 
mitochondrial complex V or ATP Synthase; and (F) HAD, 3-hydroxyacyl coenzyme a dehydrogenase, is illustrated in response to age and across skeletal muscles. 
Example blots for one analysis from one animal are shown above the graph. Values are means ± SD. In figure, a indicates significant difference in age within a skeletal 
muscle, p < .05; b shows significant difference between soleus (black) from both quadricep (grey) and lateral gastrocnemius (white) within the same age, p < .05; and 
c indicates differences between quadricep and gastrocnemius within the same age, p < .05.
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Figure 2. Skeletal muscle respirometric analysis. Mass-specific respiration across muscle groups in (A) young and (C) mature animals. Mass-specific respiration 
with age in mouse (E) quadricep, (G) soleus, and (I) gastrocnemius skeletal muscles. Mitochondrial-specific respiration controlling for mitochondrial content, as 
assessed by mitochondrial complex II protein expression (82), across skeletal muscles in (B) young and (D) mature animals. Mitochondrial-specific respiration with 
age in mouse (F) quadricep, (H) soleus, and (J) gastrocnemius skeletal muscles. LN, leak respiration without adenylates; PEFT, maximal fatty acid oxidation; PCI, sub-
maximal state 3 respiration through mitochondrial complex I (CI); P, maximal state 3 respiration–oxidative phosphorylation capacity; Cyt C, cytochrome c, internal 
test of mitochondrial membrane integrity; ETS, electron transport system capacity; and PCII, submaximal state 3 respiration through mitochondrial complex II (CII). 
Data presented as mean ± SD. *, **, and *** indicate significant difference of p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
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Differences across young muscle groups were evident 
between both QUAD and SOL versus GAST (p = .023 and 
.001, respectively) and across mature muscle groups with 
QUAD greater than SOL (p = .020).
Respiratory Capacity and Control Specific to 
β-Oxidation
Only values of fatty acid oxidative capacity, PETF, were 
adjusted to account for the differences in HAD protein 
expression (Figure 1D). PETF (pmol O2/min/HAD) increased 
with age in QUAD (p  =  .004) and showed a tendency to 
increase in GAST (p = .065) (Figure 5). Differences across 
young and mature muscle groups were evident with both 
QUAD and GAST far below SOL (p < .001). Though PETF, 
when controlling for HAD, did not change in SOL (Figure 5), 
the coupling efficiency during β-oxidation diminished with 
age (Table 2). Despite this decrease with age, the coupling 
control of electron transport during β-oxidation in SOL was 
significantly better than younger and older QUAD (p = .01 
and .05, respectively). Coupling control during fat oxida-
tion did not change with age in QUAD or GAST, though it 
did differ between young SOL and GAST (p =  .05). This 
difference was lost with age (Table 2).
Discussion
The aim of this study was to analyze the effect of bio-
logical aging on respiratory capacities and mitochondrial 
coupling control across different skeletal muscle types as 
a function of age. Our main findings are (i) mitochondrial 
function is dependent on skeletal muscle type, irrespec-
tive of age; (ii) submaximal state 3 respiration specific to 
CI, PCI, increased in both QUAD and GAST but decreased 
in SOL when controlling for complex I  protein expres-
sion; (iii) coupling control during PCI was also lost with 
age in GAST and indicated a tendency for deterioration 
in QUAD but remained unchanged in SOL; (iv) maximal 
state 3 respiration and oxidative phosphorylation capacity, 
P, increased with age in QUAD and GAST but not SOL 
when controlling for CIII protein expression; and finally 
(v) although the capacity for fat respiration increased 
with age in QUAD when controlling for differences in 
HAD protein expression across skeletal muscle types, the 
Figure 3. Respiratory capacity and control through mitochondrial complex 
I (CI). Submaximal state 3 respiratory capacity specific to CI (PCI) when con-
trolling for CI protein expression with age in (A) quadricep, (B) soleus, and (C) 
gastrocnemius skeletal muscles. *, **, and *** indicate significant difference of 
age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
Table 2. Mitochondrial Coupling Efficiency With Age
Young QUAD Mature QUAD Young SOL Mature SOL Young GAST Mature GAST
LCRETF 0.54 ± 0.16† 0.53 ± 0.18† 0.33 ± 0.09*,†,‡ 0.41 ± 0.05*,† 0.57 ± 0.29‡ 0.52 ± 0.10
LCRCI 0.15 ± 0.03†,§ 0.20 ± 0.07†,§ 0.24 ± 0.11†,‡ 0.29 ± 0.06†,‡ 0.12 ± 0.06*,‡ 0.17 ± 0.03*,‡
LCRCII 0.69 ± 0.13 0.76 ± 0.07 0.54 ± 0.25 0.72 ± 0.11 0.68 ± 0.19 0.66 ± 0.11
Notes: Leak control ratios (LCR) as indices of mitochondrial coupling and respiratory control across different skeletal muscles with age. GAST = gastrocnemius; 
LCRETF = coupling efficiency of electron transfer through electron-transferring flavoprotein (ETF) during β-oxidation; PCI = coupling efficiency of electron transfer 
during respiration through mitochondrial complex I (CI); PCII = coupling efficiency of electron transfer during respiration through mitochondrial complex II (CII); 
QUAD = quadriceps; SOL = soleus.
*,†,‡Effect of age, difference between QUAD vs SOL, and difference in SOL vs GAST, respectively, with p < .05.
§Difference with age, p = .085. Data are presented as mean ± SD.
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coupling control during fat oxidation worsened with age 
only in SOL.
Variations in Mitochondrial Function Across 
Fiber Types
There is some dispute on whether differences in 
respiratory capacity fluctuate across different skeletal 
muscle types that vary in their biochemical makeup, tailoring 
oxidative function to specific metabolic demand (83). Initial 
reports suggested that respiratory differences could be 
accounted for simply by the differences in mitochondrial 
content (50,84). This has since been refuted as various 
skeletal muscles have been shown to express respiratory 
differences across muscle types (46,47,85,86). We recently 
substantiated these differences in mitochondrial function 
across muscle types as respiration capacities in both GAST 
and QUAD were greater than those in SOL at PCI, PCII, P, 
and ETS respiratory states when normalizing mass-specific 
respiration to citrate synthase activity (87). Although it 
seems evident that differences in function exist across 
different skeletal muscle fiber types, even when controlling 
for the disproportionate expression of mitochondria, the data 
Figure 4. Respiratory capacity and control through mitochondrial complex 
III (CIII). Maximal state 3 respiration and oxidative phosphorylation capacity 
(P) when controlling for CIII protein expression with age in (A) quadricep, (B) 
soleus, and (C) gastrocnemius skeletal muscles. *, **, and *** indicate signifi-
cant difference of age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
Figure 5. Respiratory capacity and control through electron transferring fla-
voprotein (ETF) during maximal fat respiration. Submaximal state 3 respiratory 
capacity specific to the capacity for fat oxidation and electron transfer through 
ETF (PETF) when controlling for 3-hydroxyacyl coenzyme a dehydrogenase 
(HAD) protein expression with age in (A) quadricep, (B) soleus, and (C) gas-
trocnemius skeletal muscles. *, **, and *** indicate significant difference of 
age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively. # indicates a tendency of a dif-
ference with age, p = .065.
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presented here demonstrate how important normalization of 
the mass-specific respirometric values can be to overall data 
interpretation.
Our findings specific to mitochondrial protein expres-
sion are contrary to studies suggestive of a progressive loss 
of mitochondria with age (34,48). We cannot exclude the 
possibility that some mitochondrial protein/fragments may 
have been lost as a result of our homogenization and cen-
trifugation procedures. Thus, we cannot confirm that our 
mitochondrial protein determination is representative of 
the total per volume of muscle mass, possibly explaining 
the differences between studies. Alternatively, however, 
our results are in accordance with several studies report-
ing negligible to minor changes in mitochondrial protein 
expression with age, including an increase of expression 
that is dependent on skeletal muscle type (32,33,45,88). 
There is also evidence in mice of increased skeletal muscle 
mitochondrial protein synthesis with advancing age (88). 
Although it is unlikely that the preferential loss of mito-
chondrial protein during homogenization and centrifuga-
tion procedures biased our results, we cannot definitively 
exclude this possibility.
Skeletal Muscle Mitochondrial Respiratory Capacity 
and Control Across Skeletal Muscle Types With Age
Mitochondrial respiratory capacities across several dif-
ferent states diminished with age in QUAD and SOL 
(Figure  2F and H). These results coincide with previous 
reports where oxidative capacity is reported to decline 
with age in either QUAD or mixed muscle homogenates 
(19,31,33,35,36,38,39). Alternatively, mitochondrial res-
piratory capacities across all states increased with age in 
GAST (Figure  2J). The increase in respiratory capacity 
with age in GAST also corresponds with previous work 
that demonstrated a greater reliance with age of oxidative 
phosphorylation for ATP synthesis in primarily type 2 fast-
twitch glycolytic skeletal muscle (41,42,89).
Mitochondria serve as a primary source of in vivo 
oxidant production (2–5) with the primary oxidant 
production occurring at CI (6–8) and CIII (9–14). Despite 
the macro decreases in mitochondrial-specific respiratory 
capacity in QUAD (Figure  2F), respiration and electron 
flow specifically through CI and CIII increased (Figures 3A 
and 4A). Coupling control during PCI also had a tendency to 
deteriorate in QUAD (p = .085) in response to age (Table 2). 
Respiration and electron flow specifically through CI and 
CIII also increased in GAST, whereas coupling control 
during PCI worsened with age (Table 2). Electron coupling 
control is indicative of oxidant production as mitochondrial 
production of superoxide is closely related to mitochondrial 
coupling efficiency during respiration (9). Moreover, 
increased mitochondrial respiration capacity also results 
in increased oxidative damage and shorter life span (27). 
Respiratory capacity through CI diminished, whereas 
capacity through CIII and electron coupling control through 
CI remained unaffected by age in the slow-twitch oxidative 
SOL (Figures 3B and 4B, and Table  2, respectively). 
Highly glycolytic skeletal muscle has been shown to have 
higher oxidant production with a reciprocal lower capacity 
for oxidant scavenging compared with highly oxidative 
muscle (90). Predominantly fast-twitch skeletal muscle 
also has been reported to accrue age-associated oxidative 
damage, as assessed with protein carbonyl profiles across 
different skeletal muscle types, more rapidly than slow-
twitch oxidative muscle (91). Collectively, the results from 
this study, in corroboration with these previous findings, 
provide the direct evidence of a predisposition to ETS 
dysfunction with age in type 2 fast-twitch glycolytic skeletal 
muscle that is not observed in type 1 slow-twitch oxidative 
muscle and has been previously suggested in humans using 
indirect metabolic imaging techniques (46,47). Preliminary 
evidence suggests that caloric restriction (92) and exercise 
(93) reduce mitochondrial oxidant production and may 
serve to counterbalance these age-related impairments in 
electron transport.
Ratios of coupling control are based on the supposi-
tion that a tightly coupled system can be distinguished 
from a dyscoupled system by the magnitude of difference 
between two steady respiratory states with identical sub-
strate supply (94). We used leak control ratios as our indi-
ces of mitochondrial coupling control efficiency (Table 2). 
Leak control ratios are produced between two reciprocal 
respiratory states; a low flux state (ie, LN with malate and 
pyruvate, state 4 respiration) compared with an equiva-
lent high respiratory flux state (ie, PCI, submaximal state 
3 respiration). An identical substrate supply is necessary 
to pair corresponding states. Flux control ratios demon-
strate coupling efficiency using a theoretical minimum of 
0.0, which indicates a fully coupled system, to a value of 
1.0 representing a fully noncoupled or dyscoupled system 
(63). Although we show evidence of a loss of coupling 
control with aging during PCI in GAST and a tendency in 
QUAD, unfortunately coupling efficiency during maximal 
state 3 respiration could not be determined with the titra-
tion protocols utilized as there was no reciprocal leak state 
measured for P.
Respiratory Capacity and Control of Fat Oxidation 
With Aging
We found that the capacity for fat respiration increased 
with age without a reciprocal loss of coupling efficiency 
during β-oxidation in QUAD when controlling for 
differences in HAD protein expression (Figure 5 and Table 2, 
respectively). Conversely, capacity for fat respiration was 
unaltered with age in SOL, though the coupling control 
during fat oxidation diminished. Neither respiratory 
capacity nor control of fat oxidation was altered in GAST. 
Skeletal muscle intramyocellular lipid stores increase in 
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parallel with age-related decreases in mitochondria (37). 
Moreover, intramyocellular lipid content is also reported to 
drift away from the mitochondrial reticulum with age (37). 
The dysregulation of fat metabolism within skeletal muscle 
is associated with the development of insulin resistance 
and metabolic disease (95–97). The loss of mitochondrial 
coupling efficiency in type 1 slow-twitch fibers, such as 
observed here, may in part explain the reported insulin 
resistance in healthy, lean, elderly participants (38). This is 
of interest in regards to metabolic disease as well as aging 
and merits further investigation.
Conclusions
Here, we directly demonstrate impairments of mitochon-
drial function in response to aging in skeletal muscle. The 
specific age-induced alteration in function is dependent on 
skeletal muscle type. Skeletal muscle composed primar-
ily of type 2 fast-twitch glycolytic fibers are predisposed 
to progressive impairments in mitochondrial function with 
age as type 1 slow-twitch oxidative fibers appear to protect 
against this effect.
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